Applied science may yield more translational research publications than basic science

While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

The NIH prioritizes funding for translational research, or studies that apply findings from basic science to promote human health and well-being. Since there are many different definitions of translational research and important milestones in biomedical research have yet to be defined, it is difficult to track and quantify its progress.

In their new study, Han and colleagues investigated the amount of translational research produced from three types of NIH-funded research awards between 2008 and 2014: basic and applied research grants in the behavioral and social sciences, and the Clinical and Translational Science Award, a program that specifically targets translational research. They analyzed all publications produced from those 6,387 awards and they determined what percentage of those publications could be classified as translational research. From this analysis, the researchers found that 3.9% of publications produced by basic research awards, 7.4% produced by applied research awards, and 13.4% of the CTSA program publications were translational.

The researchers' analysis of NIH-funded behavioral and social sciences research demonstrates a progression toward increased translational research as they moved across the research spectrum from basic science to applied science, with the targeted translational research program yielding the highest number of translational research publications. The researchers suggest that translational research can happen at any stage of research, with increasing frequency in applied science, and that targeted translational research programs such as CTSA appear to be effective at promoting the translation of basic and applied sciences into medical practices and meaningful health outcomes.

Xueying Han says: "Our findings suggest that translational research can happen at any stage along the research continuum, and that targeted translational research programs, such as the Clinical and Translational Science Award Program, appear to be effective at increasing the translation of basic and applied research to health outcomes."

Xueying Han, Sharon R Williams, Brian L Zuckerman.
A snapshot of translational research funded by the National Institutes of Health (NIH): A case study using behavioral and social science research awards and Clinical and Translational Science Awards funded publications.
PLoS ONE 13(5). doi: 10.1371/journal.pone.0196545.

Most Popular Now

Top 20 breaking World Pharma News of 2018

World Pharma News proudly presents the top 20 most popular breaking news from 2018. Have a wonderful 2019 New(s) Year filled with health, happiness, and spectacular succe...

FDA approves first treatment for rare blood diseas…

The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adu...

Bristol-Myers Squibb to acquire Celgene to create …

Bristol-Myers Squibb Company (NYSE:BMY) and Celgene Corporation (NASDAQ:CELG) today announced that they have entered into a definitive merger agreement under which Bristo...

Lynparza meets primary endpoint in Phase III SOLO-…

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) announced positive results from the randomised, open-label, contro...

Pediatric leukemia 'super drug' could be developed…

Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published ...

Researchers uncover new mechanism of gene regulati…

Genes contain all the information needed for the functioning of cells, tissues, and organs in our body. Gene expression, meaning when and how are the genes being read and...

Tumors backfire on chemotherapy

Some patients with breast cancer receive chemotherapy before the tumor is removed with surgery. This approach, called 'neoadjuvant' therapy, helps to reduce the size of t...

AstraZeneca announces organisational changes

AstraZeneca is today announcing organisational changes to support continued scientific innovation and commercial success in the main therapy areas as the Company enters a...

Sandoz and Pear Therapeutics announce US launch of…

Sandoz Inc., a Novartis division, and Pear Therapeutics, Inc., announced today the US commercial launch of reSET-O(TM) for patients with Opioid Use Disorder (OUD). reSET-...

Stopping cancer from recruiting immune system doub…

Cancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the body; the tumors actually put myeloid cells to...

Boehringer Ingelheim initiates a collaborative par…

Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced a technology enterprise collaboration agreement that will support Boehringer...

Pfizer initiates phase 2b/3 clinical trial for PF-…

Pfizer Inc. (NYSE: PFE) announced the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the treatment of patients with moderate to s...